Home › Company will create new swine vaccines based on advanced mucosal technology
 

Keywords :   


Company will create new swine vaccines based on advanced mucosal technology

2015-07-07 21:29:38| National Hog Farmer

Aptimmune Biologics, a mucosal vaccine company developing novel swine vaccines for PRRSV and influenza virus, has received $2.75 million of funding from Arsenal Capital Management, Fox Ventures LLC, and a group of Midwest angel investors. “PRRSV and influenza virus are a growing threat to swine health worldwide. Their combined annual economic impact on the U.S. swine industry alone is over $1.4 billion. Our new vaccine portfolio will change the management of these diseases, significantly improve swine health and producer productivity,” said Dr. read more

Tags: advanced company based create

Category:Agriculture and Forestry

Latest from this category

All news
20.05USDA moves to electronic identification tags
20.05Better pasture and hay conditions anticipated for 2024
20.05Producers to be paid grid premiums for AngusLink Beef Scores
20.05May/June 2024 Digital Edition of National Hog Farmer now available
20.05NABC hosts foreign animal disease tabletop exercise
20.05NABC hosts foreign animal disease tabletop exercise
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
20.05Several pork priorities secured in House Farm Bill
Agriculture and Forestry »
20.05USDA moves to electronic identification tags
20.05Better pasture and hay conditions anticipated for 2024
20.05Panasonic offers Fire TV, Google TV and Powered by TiVo
20.05Eutelsat reports results for the period ended 31 March 2024
20.05Producers to be paid grid premiums for AngusLink Beef Scores
20.05WCC Re-elects Tom Bowtell for Second Term as President, Recognizes Contributions of Andy Doyle
20.05May/June 2024 Digital Edition of National Hog Farmer now available
20.05DKSH Extends Distribution Agreement with KRONOS in Asia Pacific
More »